Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Antidepressant
TS-121
Другие языки:

    TS-121

    Подписчиков: 0, рейтинг: 0
    TS-121
    Clinical data
    Other names TS-1211
    Routes of
    administration    		 By mouth

    TS-121 (THY1773) is an orally active, selective vasopressin V1B receptor antagonist which is under development by Taisho Pharmaceutical for the adjunctive treatment of major depressive disorder. As of May 2017, it is in phase II clinical trials for this indication.

    See also

    External links

    • Clinical trial number NCT03093025 for "A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder" at ClinicalTrials.gov




    Новое сообщение